Vital Images and Toshiba Medical Systems’ (TYO:6502) American division secured a combined $198 million in separate supply deals with the U.S. Dept. of Defense.
Funding Roundup
Diabetes: Intuity Medical raises $5M
Intuity Medical met it $5.5 million goal in a recent funding round, SEC filings show.
Sunnyvale, Calif.-based Intuity, a spin-off of research group Sarnoff Corporation, is working to simplify diabetes management. The company’s flagship product is the POGO blood glucose monitoring system, which integrates test strips and a lancing device into one system. The POGO technology currently has only investigational device classification, according to the company’s website.
RenovoRx raises over $1M Series B round
RenovoRx closed its Series B financing round, bringing in about $1.2 million for the catheter maker.
The San Jose, Calif.-based medical device company is working on catheter technology that directly delivers fluids to the peripheral vascular system. The financing round was led by angel funding group Golden Seeds, alongside the Angels’ Forum, Astia Angels and Amidzad Partners.
Inogen plans for $75M IPO
Inogen narrowed the price range for the initial public offering it registered late last year, saying it expects to price the IPO at $16 to $18 per share.
That would make the 4.4-million-share offering worth $70.6 million to $79.4 million; if the shares sell at the midpoint, Inogen would raise about $75.0 million.
PowerVision raises $4M so far in $30M round
PowerVision is trying to fundraise $30 million, having so far brought in $4 million, according to a regulatory filing.
X-Bolt Orthopaedics lands nearly $3M in funding
X-Bolt Orthopaedics raised $2.5 million (€1.8m) to put its hip fracture repair device on the market.
Dublin-based X-Bolt develops and manufactures devices for hip fractures. The company’s marquee product is an expanding bolt placed where the hip fractures, designed to help decrease the need for repeat surgeries.
Medtronic, J&J put more skin in PowerVision’s intraocular lens
California-based PowerVision touted another round of fundraising backed by some of the biggest names in medtech.
Amedica looks to $35M U.S. IPO
Medical device company Amedica said it’s planning to put up nearly 3.2 million shares at $10 to $12 apiece in an initial public offering in the U.S.
Salt Lake City-based Amedica, which makes silicon nitride-based biomaterials for medical devices, said it plans to trade under the AMDA symbol on the NASDAQ exchange.
At the midpoint of the proposed offering range, Amedica would have an initial market capitalization of $143 million.
Rehab robots: Ekso Bionics goes public, raises $20.6M
California robotics company Ekso Bionics (OTCBB:EKSO) raised $20.6 million through a private placement offering and a reverse merger that made the company a wholly owned subsidiary of Ekso Bionics Holdings.
OrthoAccel lands $5M in equity round
OrthoAccel Technologies said it brought in $5 million in an equity offering.
The Houston-based company makes the AccelaDent device, which is designed to accelerate tooth movement using sonic technology.
The $5 million came from existing backers Healthpoint Capital and S3 Ventures, along with standing stockholders, according to a press release.
Michelson Diagnostics lands $3M in Series A2 financing
Michelson Diagnostics brought in $3.2 million in its Series A2 financing round, planning on using the funds to support its VivoSight device.
England-based Michelson develops and commercializes non-invasive diagnostic and monitoring equipment. The company’s flagship product is the VivoSight OCT scanner, which produces high definition images of the layers of the skin and subsurface features, allowing physicians and dermatologists to make accurate treatment decisions concerning what they see.